Regenerative medicine company Orthocell Ltd ( ASX:OCC , OTC:ORHHF) will host an investor webinar on Thursday, October 22, 2026, providing an update on its September quarter results, the US rollout of Remplir and other strategic initiatives.
The webinar will follow the release of Orthocell's quarterly results for the period ended September 30, 2026, and will give investors an overview of the company's financial and operational progress.
Chief executive officer and managing director Paul Anderson will present alongside chief financial officer Jim Piper and chief commercial officer Adam Wood.
The briefing will cover progress with Orthocell's Remplir nerve repair product in the US market, as well as updates on the company's broader commercial and strategic priorities.
The webinar will begin at 8.00am AWST and 11.00am AEDT on Thursday, October 22, 2026.
Investor Briefing – Webinar
When: 8.00am AWST | 11.00am AEDT, Thursday, October 22, 2026
Register Now: Click to Register
Participants who register will receive a confirmation email with details on how to join the webinar.
